2025³â 08¿ù 06ÀÏ ¼ö¿äÀÏ
 
 
  ÇöÀçÀ§Ä¡ > Àαⴺ½º

·£¼¶¿þ¾îºÎÅÍ µÅÁöµµ»ì±îÁö... ³ë·ÃÇØÁø »ç±âÇà°¢

 

Á¤Ä¡

 

°æÁ¦

 

»çȸ

 

»ýȰ

 

¹®È­

 

±¹Á¦

 

°úÇбâ¼ú

 

¿¬¿¹

 

½ºÆ÷Ã÷

 

ÀÚµ¿Â÷

 

ºÎµ¿»ê

 

°æ¿µ

 

¿µ¾÷

 

¹Ìµð¾î

 

½Å»óǰ

 

±³À°

 

ÇÐȸ

 

½Å°£

 

°øÁö»çÇ×

 

Ä®·³

 

Ä·ÆäÀÎ
Çѻ츲 ¡®¿ì¸®´Â ÇѽҸ²¡¯ ½Ò ¼Òºñ Ä·ÆäÀÎ ½Ã...
1000¸¸¿øÂ¥¸® Àΰø¿Í¿ì, °Ç°­º¸Çè Áö¿ø ¡®Æò...
 
¸ðµÎ 92498°³ÀÇ ´º½º°¡ °Ë»öµÇ¾ú½À´Ï´Ù.



Novotech Report: How In-Vivo CAR-T May Reshape Cell Therapy Econo...
SYDNEY -- With in-vivo CAR-T therapies gaining global momentum, a new whitepaper from Novotech, a leading global full-service clinical Contract Research Organization (CRO) and scientific advisory company, offers insight into this next frontier of immunotherapy. In-Vivo CAR Therapies - Global Research and Development Landscape (2025) report explores the accelerating innovation in in-vivo CAR-T (Chimeric Antigen Receptor) technologies and their potential to reshape treatment across oncology, autoi ...

¡®±ñdzġŲ »À ¹ß¶ó¹ö¸± ¹ß°ñ Àü¹®°¡¡¯ ¸ðÁý¡¦ÀÏ±Þ 100¸¸¿ø

ÀâÄÚ¸®¾Æx¾Ë¹Ù¸óxǪ¶ó´ß º¹³¯ ÀÌ»ö¾Ë¹Ù
ÀâÄÚ¸®¾Æ¿Í ¾Ë¹Ù¸ó(´ëÇ¥ÀÌ»ç À±ÇöÁØ)ÀÌ º¹³¯À» ¸Â¾Æ ġŲ Àü¹® ºê·£µå Ǫ¶ó´ß ġŲ°ú ÇÔ²² ÀÌ»ö ¾Ë¹Ù¸¦ ¸ðÁýÇÏ´Â À̺¥Æ®¸¦ ÁøÇàÇÑ´Ù°í 21ÀÏ ¹àÇû´Ù. ÀâÄÚ¸®¾Æ¿Í ¾Ë¹Ù¸óÀº ³»´Þ 3ÀϱîÁö Ǫ¶ó´ß ġŲ°ú Çù¾÷ÇØ º¹³¯ ±â³ä ÀÌ»ö °ø°í¸¦ ³»°í ‘±ñdzġŲ »À ¹Ù¸¦ ¾Ë¹Ù¸ó’°ú ‘±ñdzġŲ »À ¹ß¶ó¹ö¸± ¹ß°ñ Àü¹®°¡’¸¦ ¸ðÁýÇÑ´Ù. À̹ø À̺¥Æ®´Â ¾Ë¹Ù¸óÀÌ ÁøÇà ÁßÀÎ ´ë±Ô¸ð ÇÁ·Î¸ð¼Ç ‘2025 ¿©¸§ ¾Ë¹Ù Æä½ºÅ¸(¿©¾ËÆä)’ÀÇ ÀÏȯÀÌ´Ù. ÀâÄÚ¸®¾Æ¿Í ¾Ë¹Ù¸óÀº ¿©¸§Ã¶ ¹«´õÀ§¿Í ²ß²ßÇÑ ³¯¾¾·Î ÁöÃÄ ÀÖ´Â ±¸Á÷ÀÚµéÀ» À§ ...

ÇÑÈ­»ý¸í, ¹Ì±¹ Áõ±Ç»ç º§·Î½ÃƼ Àμö ¿Ï·á

ºÏ¹Ì ÀÚº» ½ÃÀåÀ¸·ÎÀÇ Àü·«Àû È®Àå
ÇÑÈ­»ý¸íÀº ¹Ì±¹ Áõ±Ç»ç ‘º§·Î½ÃƼ’ÀÇ ÁöºÐ 75% Àμö ÀýÂ÷¸¦ 30ÀÏ(ÇöÁö½Ã°£) ¼º°øÀûÀ¸·Î ¸¶¹«¸®Çϰí, º¸Çè Áß½ÉÀÇ Æ÷Æ®Æú¸®¿À¸¦ ³Ñ¾î ºÏ¹Ì ÀÚº» ½ÃÀåÀ¸·ÎÀÇ Àü·«Àû È®ÀåÀ» º»°ÝÈ­ÇÑ´Ù°í 31ÀÏ ¹àÇû´Ù. À̹ø º§·Î½ÃƼ Àμö´Â ±¹³» º¸Çè»ç°¡ ‘±Û·Î¹ú ÀÚº» ½ÃÀåÀÇ Á߽ɺΒÀÎ ¹Ì±¹ Áõ±Ç ½ÃÀå¿¡ ÁøÃâÇÑ ÃÖÃÊÀÇ »ç·Ê´Ù. À̷νá ÇÑÈ­»ý¸íÀº ¹Ì±¹ ÇöÁö ±ÝÀ¶»ç¸¦ ÅëÇØ ¼öÀͼºÀ» ³ôÀ̰í, ¿ì¼öÇÑ ±Û·Î¹ú ±ÝÀ¶ »óǰÀ» ±Û·Î¹ú °í°´¿¡°Ô Á¦°øÇÒ ¼ö ÀÖ´Â Ç÷§ÆûÀ» ¸¶·ÃÇß´Ù. ´º¿åÀ» °ÅÁ¡À¸·Î ÇÑ º§·Î½ÃƼ´Â ±ÝÀ¶ °Å·¡ ü°á ...
Çö´ëÂ÷, 2019 ±×·£µå¸¶½ºÅÍ Å×Å© Æä½ºÅ¸ °³ÃÖ (2019-12-20)
³Ø¼¾Å¸À̾î, ¡®°ñÇÁ¡¯ 8¼¼´ë¿¡ ½ÅÂ÷¿ë ŸÀÌ¾î °ø±Þ (2020-07-23)
ÇãÀ§Á¤º¸ ÆÇº° Ç÷§Æû ÆÑƮüũ³Ý ¸ð¹ÙÀÏ ¾Û (2021-12-31)
±âȹ°ø¿¬ ¡®¾êµé¾Æ~ ½Ó ±¸°æ °¡ÀÚ¡¯ (2023-06-10)
¾Ë¹Ù»ý 5¸í Áß 3¸í, Ű¿À½ºÅ© È®´ë¿¡ ÀÏÀÚ¸® °ÆÁ¤ (2018-11-11)
GC³ì½ÊÀÚ, ¹Ì±¹¿¡ ½Å±Ô Ç÷¾×¿ø °³¿ø (2018-11-11)
TCO Àý°¨¿¡ ÃÖÀûÈ­µÈ »õ·Î¿î ³ªÀÌÆ®·Î SSD (2022-08-04)
KB±¹¹ÎÀºÇà, ·ÎÀ̵å¹ðÅ·±×·ì°ú IB ºÎ¹® MOU (2021-09-28)
Creative Artists Agency to Acquire ICM Partners (2021-09-28)
Àå¾Ö¾Æ±³À°, À¯º¸ÅëÇÕÀ¸·Î °úÁ¦ ÇØ°áÇØ¾ß (2014-09-30)
³ó¾÷¼Õ½Ç º¸»ó ½Ã ÀÓÂ÷³ó¹Î ¡®µµÀå°ª¡¯ ÇÇÇØ ¾ø¾Ø´Ù (2015-01-30)
1ȸ ½ºÄµÀ¸·Î ¸í½Ã¾ß¡¤¾Ï½Ã¾ß ¹× ¹è¸é±¤ À̹ÌÁö ĸó (2019-12-01)
¼Ò´õºñ, ÁÖ°É·ûÀ» Å¥·¹ÀÌÅÍ·Î ¼±Á¤ (2021-06-26)
¿¡À̼ö½º, A520 ½Ã¸®Áî ¸ÞÀκ¸µå (2020-08-20)
´ë±¸½Ã Áö¿ø û³â ÆË¾÷ ·¹½ºÅä¶û û³â â¾÷ÀÚ ¸ðÁý (2019-08-29)
À¯Àüü ºÐ¼® AI ¾Ë°í¸®Áò °³¹ß Çù·Â (2021-05-10)
KB¼ÕÇØº¸Çè, °³Àοë ÀÚµ¿Â÷º¸Çè·á 1.4% ÀÎÇÏ (2022-03-16)
¼ûÀº À§±â°¡Á¤ ã¾Æ³» ¸ÂÃãÇü µ¹º½¾ÈÀü¸Á ±¸Ãà (2018-09-06)
Áß¼Ò»ç¾÷Àå ¿¡³ÊÁöÈ¿À² °³¼± Á÷Á¢ ã¾Æ°¡ Áö¿ø (2020-05-18)
»çȸÀû°æÁ¦±â¾÷ÀÇ ºñ´ë¸é ÆÇ¸Å Áö¿ø È®´ë (2020-05-18)
¾ÆÀÌ¿À´Ð 5¡¤Åõ½Ñ¡¤GV80, Ô¼ ÃÖ°íÀÇ ¼öÀÔÂ÷ (2022-01-28)
»õ¸¸±Ý ź¼Ò Á߸³ÀÇ Áß½ÉÁö·Î ÃßÁø (2020-12-20)
»ç¶÷ ³¿»õ °¡µæÇÑ 2019³â ¾Æµà~ ½Ãû·ü °æ½Å (2019-12-29)
NTT Achieves the World¡¯s Fastest Optical Transmission of ov... (2022-10-18)
ÀÌÆå½º, ¡®¾Æµ¹¶ó½ºÄð3:È«º¸ON¾ÆÀ̵¹¡¯ ¿ÏÀüü Ãâ°Ý (2022-10-18)
       [ÀÌÀü][1]....[2898][2899][2900][2901][2902][2903][2904][2905][2906]...[3700][´ÙÀ½]

°øÁö»çÇ×
´º½ºÁö ÇÑÀÚ Ç¥±â¿¡ ´ë¸¸½Ä À½Â÷ Ç¥±â '纽ÞÙó¢ ´Ï¿ì½ÃÁö' º´±â
º£³×ÇÁ·Ò º£³×ÀÎÅõ Áß¹® Ç¥±â 宝Ò¬ÜØÙÌ 宝Ò¬ì×öõ(ÜÄÒ¬ÜØÙÌ ÜÄ...
¹Ìµð¾î¾Æ¿ì¾î Mediaour ØÚ体ä²们 ØÚô÷ä²Ùú MO ¿¥¿À ØÚä² ØÚä²
¾Ë¸®¿ìºê Alliuv ä¹备: ä¹联êó备, ¾Ë¶ã Althle ä¹÷åìÌ
¾Ë¸®¾Ë Allial Áß¹® Ç¥±â ä¹××尔 ä¹××ì³
´ºÆÛ½ºÆ® New1st Áß¹® Ç¥±â 纽ììãæ(¹øÃ¼ Òïììãæ), N1 纽1
¿£ÄÚ½º¸ð½º : À̾¾ 'EnCosmos : EC' Áß¹® Ç¥±â ì¤ñµ
¾ÆÀ̵ð¾î·Ð Idearon Áß¹® Ç¥±â ì¤îè论 ì¤îèÖå
¹ÙÀÌ¿ÀÀÌ´Ï Bioini Áß¹® Ç¥±â ù±药研 ù±å·æÚ
¿À½ºÇÁ·Ò Ausfrom 奥ÞÙÜØÙÌ, À£ÇÁ·Ò Welfrom 卫ÜØÙÌ
¿¡³ÊÇÁ·Ò Enerfrom 额ÒöÜØÙÌ ¿¡³ÊÀ¯ºñ Eneruv 额Òöêó备
¾ËÇÁ·Ò Alfrom Áß¹® Ç¥±â ä¹尔ÜØÙÌ ä¹ì³ÜØÙÌ
 

ȸ»ç¼Ò°³ | ÀÎÀçä¿ë | ÀÌ¿ë¾à°ü | °³ÀÎÁ¤º¸Ãë±Þ¹æÄ§ | û¼Ò³âº¸È£Á¤Ã¥ | Ã¥ÀÓÇѰè¿Í ¹ýÀû°íÁö | À̸ÞÀÏÁÖ¼Ò¹«´Ü¼öÁý°ÅºÎ | °í°´¼¾ÅÍ

±â»çÁ¦º¸ À̸ÞÀÏ news@newsji.com, ÀüÈ­ 050 2222 0002, ÆÑ½º 050 2222 0111, ÁÖ¼Ò : ¼­¿ï ±¸·Î±¸ °¡¸¶»ê·Î 27±æ 60 1-37È£

ÀÎÅͳݴº½º¼­ºñ½º»ç¾÷µî·Ï : ¼­¿ï ÀÚ00447, µî·ÏÀÏÀÚ : 2013.12.23., ´º½º¹è¿­ ¹× û¼Ò³âº¸È£ÀÇ Ã¥ÀÓ : ´ëÇ¥ CEO

Copyright ¨Ï All rights reserved..